# Aura Biosciences

Source: https://onco.cc/companies/aura-biosciences/  
OnCo record `aura-biosciences` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Aura Biosciences is a United States-based biotechnology company running 2 late-stage cancer trials of AU-011 in melanoma and uveal melanoma.

## Summary

Aura Biosciences, based in Boston, MA, the United States, is a biotechnology company. Aura Biosciences is a clinical-stage biotechnology company developing targeted oncology therapies for ocular cancers using its proprietary Virus-Like Drug Conjugate (VDC) technology. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing AU-011 in melanoma and uveal melanoma. The largest, NCT06007690 (A Phase 3 Randomised, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma), plans to enrol 108 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Boston, MA
- Type: biotech
- Website: https://www.aurabiosciences.com

## Sources

- Official website: https://www.aurabiosciences.com
- ClinicalTrials.gov: trials led by Aura Biosciences: https://clinicaltrials.gov/search?lead=Aura%20Biosciences

## Connected records

- cancers: [Melanoma](https://onco.cc/cancers/melanoma/), [Uveal melanoma](https://onco.cc/cancers/uveal-melanoma/)
- trials: [A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma](https://onco.cc/trials/nct06007690/), [Suprachoroidal Administration in Subjects With Metastases to the Choroid](https://onco.cc/trials/nct06643884/)

---
JSON: https://onco.cc/api/v1/entities/aura-biosciences.json